Evergrade Healthcare Products Sdn Bhd · 80-04 · MALAYSIA
For Evergrade Healthcare Products Sdn Bhd, import alert is 80-04; country is MALAYSIA; import alert name is "Surveillance and Detention Without Physical Examination of Surgeon's and Patient Examination Gloves"; product code is 80 F - - MC Glove, Patient Examination | 80 L - - YY Glove, Patient Examination, Latex | 80 L - - YZ Glove, Patient Examination, Vinyl | 80 L - - ZA Glove, Patient Examination, Poly | 80 L - - ZC Glove, Patient Examination, Specialty; date published is 09/16/2009; address is Lot 2783 , 7 Jalan Bakri , Muar, Johor MALAYSIA, verified against its source on 2026-09-30.
- Firm
- Evergrade Healthcare Products Sdn Bhd verified
- Import alert
- 80-04
- Import alert name
- "Surveillance and Detention Without Physical Examination of Surgeon's and Patient Examination Gloves"
- Country
- MALAYSIA verified
- Address
- Lot 2783 , 7 Jalan Bakri , Muar, Johor MALAYSIA verified
- Date published
- 09/16/2009 verified
- Product code
- 80 F - - MC Glove, Patient Examination | 80 L - - YY Glove, Patient Examination, Latex | 80 L - - YZ Glove, Patient Examination, Vinyl | 80 L - - ZA Glove, Patient Examination, Poly | 80 L - - ZC Glove, Patient Examination, Specialty each item verified
- Product
- A Warning Letter has been issued to this firm citing adulteration within the meaning of Section 501(h) of the Federal Food; Drug and Cosmetic Act as documented by recurring violations. Future glove shipments are subject to refusal of admission pursuant to Section 801(a)(1). Non-violative analyses may not be sufficient to remove the appearance of a violation for manufacturers/shippers Level 3 Detention. | A Warning Letter has been issued to this firm citing adulteration within the meaning of Section 501(h) of the Federal Food; Drug and Cosmetic Act as documented by recurring violations. Future glove shipments are subject to refusal of admission pursuant to Section 801(a)(1). Non-violative analyses may not be sufficient to remove the appearance of a violation for manufacturers/shippers Level 3 Detention. | A Warning Letter has been issued to this firm citing adulteration within the meaning of Section 501(h) of the Federal Food; Drug and Cosmetic Act as documented by recurring violations. Future glove shipments are subject to refusal of admission pursuant to Section 801(a)(1). Non-violative analyses may not be sufficient to remove the appearance of a violation for manufacturers/shippers Level 3 Detention. | A Warning Letter has been issued to this firm citing adulteration within the meaning of Section 501(h) of the Federal Food; Drug and Cosmetic Act as documented by recurring violations. Future glove shipments are subject to refusal of admission pursuant to Section 801(a)(1). Non-violative analyses may not be sufficient to remove the appearance of a violation for manufacturers/shippers Level 3 Detention. | A Warning Letter has been issued to this firm citing adulteration within the meaning of Section 501(h) of the Federal Food; Drug and Cosmetic Act as documented by recurring violations. Future glove shipments are subject to refusal of admission pursuant to Section 801(a)(1). Non-violative analyses may not be sufficient to remove the appearance of a violation for manufacturers/shippers Level 3 Detention. each item verified
- FDA notes
- *** Level 3 (12/21/1999)Note | *** Level 3 (12/21/1999)Note | *** Level 3 (12/21/1999) Note | *** Level 3 (12/21/1999)Note | *** Level 3 (12/21/1999)Note each item verified
What the source says
Evergrade Healthcare Products Sdn Bhd Date Published : 09/16/2009 Lot 2783 , 7 Jalan Bakri , Muar, Johor MALAYSIA
— accessdata.fda.gov, retrieved 2026-09-15
Where each value comes from
The values above are stated away from the sentence quoted with the answer, so the passage that states them is shown here too.
Product code, Product and FDA notes
80 F - - MC Glove, Patient Examination Date Published: 09/16/2009 Desc: A Warning Letter has been issued to this firm citing adulteration within the meaning of Section 501(h) of the Federal Food; Drug and Cosmetic Act as documented by recurring violations. Future glove shipments are subject to refusal of admission pursuant to Section 801(a)(1). Non-violative analyses may not be sufficient to remove the appearance of a violation for manufacturers/shippers Level 3 Detention. Notes: *** Level 3 (12/21/1999)Note 80 L - - YY Glove, Patient Examination, Latex Date Published: 09/16/2009 Desc: A Warning Letter has been issued to this firm citing adulteration within the meaning of Section 501(h) of the Federal Food; Drug and Cosmetic Act as documented by recurring violations. Future glove shipments are subject to refusal of admission pursuant to Section 801(a)(1). Non-violative analyses may not be sufficient to remove the appearance of a violation for manufacturers/shippers Level 3 Detention. Notes: *** Level 3 (12/21/1999)Note 80 L - - YZ Glove, Patient Examination, Vinyl Date Published: 09/16/2009 Desc: A Warning Letter has been issued to this firm citing adulteration within the meaning of Section 501(h) of the Federal Food; Drug and Cosmetic Act as documented by recurring violations. Future glove shipments are subject to refusal of admission pursuant to Section 801(a)(1). Non-violative analyses may not be sufficient to remove the appearance of a violation for manufacturers/shippers Level 3 Detention. Notes: *** Level 3 (12/21/1999) Note 80 L - - ZA Glove, Patient Examination, Poly Date Published: 09/16/2009 Desc: A Warning Letter has been issued to this firm citing adulteration within the meaning of Section 501(h) of the Federal Food; Drug and Cosmetic Act as documented by recurring violations. Future glove shipments are subject to refusal of admission pursuant to Section 801(a)(1). Non-violative analyses may not be sufficient to remove the appearance of a violation for manufacturers/shippers Level 3 Detention. Notes: *** Level 3 (12/21/1999)Note 80 L - - ZC Glove, Patient Examination, Specialty Date Published: 09/16/2009 Desc: A Warning Letter has been issued to this firm citing adulteration within the meaning of Section 501(h) of the Federal Food; Drug and Cosmetic Act as documented by recurring violations. Future glove shipments are subject to refusal of admission pursuant to Section 801(a)(1). Non-violative analyses may not be sufficient to remove the appearance of a violation for manufacturers/shippers Level 3 Detention. Notes: *** Level 3 (12/21/1999)Note
— all from accessdata.fda.gov, retrieved 2026-09-15
Source
- accessdata.fda.govhttps://www.accessdata.fda.gov/cms_ia/importalert_229.html